Curr Neuropharmacol (2009) 7(1):6574.10.2174/157015909787602823 5 BlesaJTrigo-DamasIQuiroga-VarelaAJackson-LewisVR
Focus on rest and tissue protection
February 2025: Researchers published another study linking semaglutide use to the eye condition nonarteritic anterior ischemic optic neuropathy (NAION)
The precision approach to peptide dosing for weight loss requires attention to timing, titration, cycling, and individual response monitoring
Personal Treatment Plan: Our team creates personalized IV drip therapy treatment plans Administration of IV Therapy: A member of our experienced medical staff will administer the IV fluids intravenously
Use of JARDIANCE for this indication is supported by evidence from a 26-week double-blind, placebo-controlled clinical trial, with a double-blind active treatment safety extension period of up to 52 weeks in 157 pediatric patients aged 10 to 17 years with type 2 diabetes mellitus and a pediatric pharmacokinetic study [see Clinical Pharmacology (12.3) and Clinical Studies (14.2)]